International Conference on Pharmacy and Drug Interactions
ICPDI
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track explores the latest developments in pharmacology, focusing on drug interactions and their implications for patient care. Researchers are invited to present findings that enhance our understanding of pharmacokinetics and pharmacodynamics.
SDG 3
SDG 4
This session will highlight novel approaches in medicinal chemistry aimed at improving drug efficacy and safety. Presentations will cover the design, synthesis, and evaluation of new therapeutic agents.
SDG 3
SDG 9
This track focuses on the role of clinical pharmacy in optimizing medication therapy management. Discussions will include strategies for improving patient outcomes through effective drug therapy and monitoring.
SDG 3
SDG 4
This session addresses the critical aspects of medication safety and strategies for minimizing adverse drug reactions. Participants will share best practices and research findings related to risk assessment and management in pharmacy.
SDG 3
SDG 4
This track showcases cutting-edge research in pharmaceutical sciences, emphasizing the development of new drugs and therapies. Researchers are encouraged to present their findings on innovative drug formulations and delivery systems.
SDG 3
SDG 9
This session will explore innovative therapeutic approaches in drug therapy, including personalized medicine and biologics. Presentations will focus on the integration of new technologies in treatment regimens.
SDG 3
SDG 9
This track emphasizes the importance of patient-centered care in pharmacy practice. Discussions will center on strategies for enhancing patient engagement and adherence to medication regimens.
SDG 3
SDG 10
This session will delve into the principles of drug safety and the role of pharmacovigilance in monitoring drug interactions. Participants will discuss methodologies for reporting and analyzing adverse drug events.
SDG 3
SDG 4
This track highlights the significance of interprofessional collaboration in enhancing medication management and patient care. Presentations will focus on successful models of teamwork among healthcare professionals.
SDG 3
SDG 17
This session will explore the evolving landscape of pharmacy education and its impact on practice. Topics will include curriculum development, experiential learning, and the integration of technology in pharmacy training.
SDG 4
SDG 9
This track invites discussions on the global implications of drug interactions and their management across different healthcare systems. Researchers will present data and case studies that illustrate the challenges and solutions in diverse settings.
SDG 3
SDG 10